Navigation Links
10-Week "Biotech Entrepreneur Educational Program" Enrolling in New York City
Date:12/11/2012

NEW YORK, Dec. 11, 2012 /PRNewswire/ -- Kauffman FastTrac® in conjunction with Propero/Healthcare Accelerator (Propero/HCA) announces the launch of FastTrac® LifeSciences™, a 10-week professional business course designed specifically for aspiring entrepreneurs who either have an idea for a science business or have already started a business and need a plan to successfully grow.

Instructed by Laurence "Larry" Chaityn, founder of Propero/HCA and Global Head Healthcare Investment Banking at Kaminski Partners, the FastTrac LifeSciences course will provide participants a forum to:

  • Test their business' product/service, patient base, financial plan and technological viability
  • Find the target market for their business and discover its competitive advantage
  • Learn how to value their business and raise money from funding sources
  • Determine the stages to profitability
  • Learn successful regulatory strategies, including correct protocol, achievable endpoints and correct patient participants
  • Understand reimbursement strategies including differing reimbursement environments, multiple codes, limited reimbursement and attended monitoring

FastTrac LifeSciences will be held at Loeb & Loeb, 345 Park Avenue, 21st floor Conference Center. Classes begin Monday, January 28, 2013 at 5:30 p.m. EST and will be held each successive Monday for 10 weeks.  Space is limited. Participants can register at http://properohca.affiliate.fasttrac.org/.

"Interesting science and a novel mechanism of action are important when launching a biotechnology company, but success hinges on a multitude of factors, many of which occur in the boardroom and not at the bench," Chaityn said. "I look forward to helping life sciences entrepreneurs develop the essential business strategies that will allow them to navigate the hurdles of today's regulatory and financial landscape."

About Laurence Chaityn:
Laurence "Larry" Chaityn is the founder of Propero/HCA and Managing Director and Global Head Healthcare Investment Banking at Kaminski Partners.  With more than 12 years of healthcare and life science consulting experience, he has built expertise in deal sourcing, deal review, due diligence investigation and client facing operations. Chaityn has worked with executive and senior management at Johnson & Johnson, Pfizer, Bayer Pharmaceuticals, Merck, Bristol Meyers Squibb (BMS) and others.

About Propero/Healthcare Accelerator:
ProperoHCA's mandate is to grow Healthcare/Life Science companies. One of the key assets is the network of nationwide hospital CEOs, CFOs & CAOs. This relationship, coupled with our knowledge of the healthcare landscape enables us to map specific hospital challenges and business initiatives for our clients. The overarching goal is to create a scalable sales organization that minimizes the cost of customer acquisition, streamlines the overall sales cycle and maximizes the revenue yield per employee.

Media Contact:
Tiberend Strategic Advisors, Inc.
Claire Sojda
212-827-0020
csojda@tiberend.com


'/>"/>
SOURCE Kauffman FastTrac
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
2. Minority Biomedical Entrepreneurship Conference
3. Entrepreneurs to Eat Problems for Breakfast in San Diego
4. Leading Technology Incubator Honors Extraordinary Entrepreneurs
5. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
6. Western Carolina University, College of Business Appoints New Director of Entrepreneurship and Innovation
7. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
8. Hawaii Tech Asia Takes Hawaii & US Entrepreneurs To China
9. Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative
10. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
11. NIRI San Diego May Meeting: Seasoned IROs Discuss "Tips & Tactics for Establishing and Maintaining A Successful Investor Relations Program"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... , ... Executive search firm, Slone Partners, announces the placement ... a distinguished life sciences expert with a proven track record in strategic global ... range of services related to laboratory testing and analysis for the pharmaceutical, medical ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture ... added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). ... USA ) and the US National Institutes of Health. ... ... Logo ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team led ... grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. The ... treating coronary artery disease (CAD). Lam is an assistant professor at the Department ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March 24, ... Maxwell Biotech Venture Fund (MBVF), today announced positive results ... to the standard drug therapy regimen in patients with ... molecule drug discovered by scientists at Sequella, Inc. ( ... of Health. A total of 140 ...
Breaking Biology Technology:
(Date:3/9/2017)... Australia , March 9, 2017 /PRNewswire/ ... at the prestigious World Lung Imaging Workshop at the ... Fouras , was invited to deliver the latest data ... This globally recognised event brings together leaders at the ... latest developments in lung imaging. "The ...
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
Breaking Biology News(10 mins):